October 28, 2009 - At the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Nov. 1-5 in Chicago, Elekta will showcase new tools that demonstrate the IGRT-pioneer’s continued leadership in oncology imaging. Highlights include Intuity*and Symmetry* advanced image-guidance solutions that build upon the company’s existing expertise.

“We are proud to once again introduce practice-changing innovations in imaging that demonstrate Elekta’s continued leadership in IGRT,” said Tomas Puusepp, president and CEO of Elekta. “Clinicians have long understood that Elekta will provide them with intelligent tools that enhance their workflow and patient’s experience and now our collaboration with research partners has resulted in two new imaging products, Intuity and Symmetry.”

Intuity, Elekta’s next release of IGRT software, will allow clinicians to understand continuous changes in the positional relationships of both tumor and healthy tissues at the time of treatment. For the first time, this unique innovation will allow accurate patient repositioning to ensure target coverage without inadvertently placing organs at risk into the beam path.

Symmetry will be the next generation of image guidance, creating new solutions for motion management. This unique and patented innovation will allow clinicians to accurately quantify the set-up changes required to accommodate ‘baseline shifts’ (tumor path changes between treatments). Symmetry’s use of anatomically correlated guidance is an alternative to gating and offers significantly shorter treatment times with less set-up complexity.

*Intuity and Symmetry are feature sets of XVI 4.5, works in progress requiring a 510(k) review and not yet available in the United States.

**Integrity is a works in progress requiring 510(k) review and not yet available in the United States.

For more information: www.elekta.com


Related Content

News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 14, 2022
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 22, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

Time October 22, 2021
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical ...

Time October 27, 2020
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
Subscribe Now